C. Klabunde

发表

Assessing Comorbidity Using Claims Data: An Overview

C. Klabunde, J. Warren, J. Legler, 2002, Medical care.

Physician use of genetic testing for cancer susceptibility: results of a national survey.

R. Croyle, R. Ballard‐Barbash, K. Srinath, 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Use of Next-Generation Sequencing Tests to Guide Cancer Treatment: Results From a Nationally Representative Survey of Oncologists in the United States

Naoko I Simonds, J. Struewing, R. Schilsky, 2018, JCO precision oncology.

Vital Signs: Colorectal Cancer Screening Test Use — United States, 2012

C. Klabunde, M. Plescia, D. Joseph, 2013, MMWR. Morbidity and mortality weekly report.

Comorbidity-Adjusted Life Expectancy: A New Tool to Inform Recommendations for Optimal Screening Strategies

Zhuoqiao Wang, Iris Lansdorp-Vogelaar, Hyunsoon Cho, 2013, Annals of Internal Medicine.

Challenges in Meeting Healthy People 2020 Objectives for Cancer-Related Preventive Services, National Health Interview Survey, 2008 and 2010

C. Klabunde, K. Cronin, Martin L. Brown, 2014, Preventing chronic disease.

Development of a comorbidity index using physician claims data.

J L Warren, C. Klabunde, J. Warren, 2000, Journal of clinical epidemiology.

Physicians' preferences for hospice if they were terminally ill and the timing of hospice discussions with their patients.

K. Kahn, N. Keating, C. Klabunde, 2014, JAMA internal medicine.

Evaluating Population-Based Screening Mammography Programs Internationally.

C. Klabunde, Carrie N Klabunde, Rachel Ballard-Barbash, 2007, Seminars in breast disease.

Quality assurance in follow-up and initial treatment for screening mammography programs in 22 countries.

S. Taplin, C. Klabunde, N. Ohuchi, 2002, International journal for quality in health care : journal of the International Society for Quality in Health Care.

Risks and rewards of using prepaid vs. postpaid incentive checks on a survey of physicians

G. Willis, C. Klabunde, Kristine F Wiant, 2018, BMC Medical Research Methodology.

Sources of Support for Studies That Inform Recommendations of the Community Preventive Services Task Force

Shawna L. Mercer, S. Mercer, C. Klabunde, 2020, Public health reports.

Association of polypectomy techniques, endoscopist volume, and facility type with colonoscopy complications.

A. Chukmaitov, C. Klabunde, J. Warren, 2013, Gastrointestinal endoscopy.

Racial and ethnic trends of colorectal cancer screening among Medicare enrollees.

Chyke A Doubeni, R. Fletcher, C. Klabunde, 2010, American journal of preventive medicine.

Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence.

E. Feuer, A. Mariotto, Hyunsoon Cho, 2013, American journal of epidemiology.

Comparing colorectal cancer screening and immunization status in older americans.

C. Klabunde, N. Breen, H. Meissner, 2007, American journal of preventive medicine.

Colorectal cancer screening barriers and facilitators in older persons.

C. Klabunde, I. Guessous, Robert A. Smith, 2010, Preventive medicine.

Oncologists’ perspectives on post‐cancer treatment communication and care coordination with primary care physicians

D. Haggstrom, K. Kahn, N. Keating, 2017, European Journal of Cancer Care.

Oncologist Confidence in Genomic Testing and Implications for Using Multimarker Tumor Panel Tests in Practice

C. Klabunde, A. Freedman, S. Gray, 2020, JCO precision oncology.

Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison.

C. Klabunde, J. Warren, A. Potosky, 1999, JAMA.

Association of Regional Variation in Primary Care Physicians’ Colorectal Cancer Screening Recommendations with Individual Use of Colorectal Cancer Screening

G. Fitzmaurice, R. Hiatt, J. Haas, 2007, Preventing chronic disease.

Physicians' Colorectal Cancer Screening Discussion and Recommendation Patterns

C. Klabunde, S. Kobrin, J. L. Smith, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Variation in Primary Care Physicians’ Colorectal Cancer Screening Recommendations by Patient Age and Comorbidity

D. Haggstrom, C. Klabunde, J. L. Smith, 2012, Journal of General Internal Medicine.

Multilevel predictors of colorectal cancer screening use in California.

C. Klabunde, D. Stinchcomb, N. Breen, 2013, The American journal of managed care.

Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population

Deborah Schrag, C. Klabunde, J. Warren, 2002, Medical care.

Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer

V. Shavers, J. Moul, C. Klabunde, 2004, Journal of General Internal Medicine.

Racial differences in initial treatment for clinically localized prostate cancer

F. Gilliland, C. Klabunde, A. Potosky, 2003, Journal of General Internal Medicine.

Emerging approaches to multiple chronic condition assessment

J. Silber, J. Suls, C. Klabunde, 2022, Journal of the American Geriatrics Society.

Breast cancer screening beliefs, recommendations and practices

C. Klabunde, N. Breen, H. Meissner, 2011, Cancer.

Breast and colorectal cancer screening: U.S. primary care physicians' reports of barriers.

C. Klabunde, N. Breen, H. Meissner, 2012, American journal of preventive medicine.

Accuracy of Self-reported Colonic Polyps: Results from the Prostate, Lung, Colorectal, and Ovarian Screening Trial Study of Colonoscopy Utilization

Patrick Wright, D. Buckman, C. Klabunde, 2020, Cancer Epidemiology, Biomarkers & Prevention.

Variations in Oncologist Recommendations for Chemotherapy for Stage IV Lung Cancer: What Is the Role of Performance Status?

K. Kahn, N. Keating, R. Fletcher, 2016, Journal of oncology practice.

Breast and cervical cancer screening programme implementation in 16 countries

Julietta Patnick, C. Klabunde, J. Patnick, 2010, Journal of medical screening.

Participation rates for organized colorectal cancer screening programmes: an international comparison

J. Bulliard, Montse García, C. Klabunde, 2015, Journal of medical screening.

Factors associated with oncologist discussions of the costs of genomic testing and related treatments.

Zhiyuan Zheng, Helmneh M Sineshaw, C. Klabunde, 2019, Journal of the National Cancer Institute.

Life tables adjusted for comorbidity more accurately estimate noncancer survival for recently diagnosed cancer patients.

Eric J Feuer, Zhuoqiao Wang, Hyunsoon Cho, 2013, Journal of clinical epidemiology.

Data Sources for Measuring Comorbidity: A Comparison of Hospital Records and Medicare Claims for Cancer Patients

C. Klabunde, J. Warren, L. Harlan, 2006, Medical care.

National Evidence on the Use of Shared Decision Making in Prostate-Specific Antigen Screening

C. Klabunde, D. Frosch, N. Breen, 2013, The Annals of Family Medicine.

A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients.

C. Klabunde, J. Warren, J. Legler, 2007, Annals of epidemiology.

Cancer, Comorbidities, and Health-Related Quality of Life of Older Adults

R. Hays, B. Reeve, A. Bierman, 2008, Health care financing review.

Colorectal cancer screening in the United States: Trends from 2008 to 2015 and variation by health insurance coverage.

S. Fedewa, C. Klabunde, J. Shapiro, 2018, Preventive medicine.

Cancer Screening Test Use — United States, 2013

C. Klabunde, T. Thompson, M. White, 2015, MMWR. Morbidity and mortality weekly report.

A national survey of primary care physicians' colorectal cancer screening recommendations and practices.

C. Klabunde, P. Frame, S. Vernon, 2003, Preventive medicine.

Physicians' recommendations for colon cancer screening in women. Too much of a good thing?

C. Klabunde, C. Richards, M. O’Malley, 1998, American journal of preventive medicine.

Trends in colorectal cancer test use in the medicare population, 1998-2005.

C. Klabunde, Martin L. Brown, P. Lapin, 2009, American journal of preventive medicine.

Time to Follow-up After Colorectal Cancer Screening by Health Insurance Type.

Chyke A Doubeni, J. Haas, Yingye Zheng, 2019, American journal of preventive medicine.

Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007.

Sally W Vernon, David Lanier, C. Klabunde, 2009, American journal of preventive medicine.

Colorectal Cancer Test Use from the 2005 National Health Interview Survey

L. Seeff, C. Klabunde, S. Vernon, 2008, Cancer Epidemiology Biomarkers & Prevention.

Patterns of Colorectal Cancer Screening Uptake among Men and Women in the United States

Nancy Breen, Sally W Vernon, Helen I Meissner, 2006, Cancer Epidemiology Biomarkers & Prevention.

Patterns and predictors of colorectal cancer test use in the adult U.S. population

R. Coates, L. Seeff, C. Klabunde, 2004, Cancer.

Adverse Events After Outpatient Colonoscopy in the Medicare Population

D. Ransohoff, A. Mariotto, C. Klabunde, 2009, Annals of Internal Medicine.

Use of Lung Cancer Screening Tests in the United States: Results from the 2010 National Health Interview Survey

P. Marcus, C. Klabunde, T. Richards, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Trends in Colorectal Cancer Test Use among Vulnerable Populations in the United States

C. Klabunde, K. Cronin, N. Breen, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Organization of Primary Care Practice for Providing Energy Balance Care

C. Klabunde, R. Ballard-Barbash, N. Pronk, 2014, American journal of health promotion : AJHP.

Trends and black/white differences in treatment for nonmetastatic prostate cancer.

B. Kramer, C. Klabunde, A. Potosky, 1998, Medical care.

Race/Ethnicity and the Intensity of Medical Monitoring Under ‘Watchful Waiting’ for Prostate Cancer

V. Shavers, J. Moul, C. Klabunde, 2004, Medical care.

National Institutes of Health Advancing Multimorbidity Research

J. Suls, C. Klabunde, M. Salive, 2021, Medical care.

Sources of Funding for Research in Evidence Reviews That Inform Recommendations of the US Preventive Services Task Force

C. Klabunde, Q. Ngo-Metzger, Jennifer Villani, 2018, JAMA.

Take the money and run? Redemption of a gift card incentive in a clinician survey

A. Tosteson, T. Onega, J. Haas, 2016, BMC Medical Research Methodology.

PS1-11: Development of an Algorithm to Classify Colonoscopy Indication Using CRN Health Plan Coded Data

Chyke A Doubeni, C. Rutter, C. Klabunde, 2012, Clinical Medicine & Research.

Overview of the SEER-Medicare Data

C. Klabunde, J. Warren, D. Schrag, 2002 .

Communicating breast cancer risk: patient perceptions of provider discussions.

B. Devellis, C. Klabunde, R. Royak-Schaler, 2002, Medscape women's health.

A National Survey of Primary Care Physicians' Methods for Screening for Fecal Occult Blood

D. Ransohoff, L. Seeff, C. Klabunde, 2005, Annals of Internal Medicine.

International comparison of performance measures for screening mammography: can it be done?

G. Rennert, B. Yankaskas, J. Bulliard, 2004, Journal of medical screening.

Use of SEER-Medicare Data for Measuring Cancer Surgery

G. Cooper, C. Klabunde, J. Warren, 2002, Medical care.

Studying Radiation Therapy Using SEER-Medicare-Linked Data

Gregory S. Cooper, G. Cooper, C. Klabunde, 2002, Medical care.

Primary Care, Economic Barriers to Health Care, and Use of Colorectal Cancer Screening Tests Among Medicare Enrollees Over Time

Chyke A Doubeni, R. Fletcher, C. Klabunde, 2010, The Annals of Family Medicine.

Cancer screening - United States, 2010.

Mary C. White, C. Klabunde, T. Thompson, 2012, MMWR. Morbidity and mortality weekly report.

Multiple Clinical Practice Guidelines for Breast and Cervical Cancer Screening: Perceptions of US Primary Care Physicians

S. Taplin, C. Klabunde, N. Breen, 2011, Medical care.

Opportunities and Challenges for the Use of Large-Scale Surveys in Public Health Research: A Comparison of the Assessment of Cancer Screening Behaviors

R. Moser, C. Klabunde, N. Breen, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Trends and outcomes of outpatient mastectomy in elderly women.

C. Klabunde, J. Warren, A. Potosky, 1998, Journal of the National Cancer Institute.

Oncologists' Selection of Genetic and Molecular Testing in the Evolving Landscape of Stage II Colorectal Cancer.

D. Haggstrom, K. Kahn, N. Keating, 2016, Journal of oncology practice.

Oncologists’ perceptions of the usefulness of cancer survivorship care plan components

D. Haggstrom, K. Kahn, N. Keating, 2020, Supportive Care in Cancer.

Enrollment of patients with lung and colorectal cancers onto clinical trials.

Katherine L Kahn, Paul J Catalano, Jane C Weeks, 2013, Journal of oncology practice.

Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?

K. Kahn, N. Keating, R. Fletcher, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Medical Oncologists' Experiences in Using Genomic Testing for Lung and Colorectal Cancer Care.

D. Haggstrom, K. Kahn, N. Keating, 2017, Journal of oncology practice.

US physicians' attitudes toward genetic testing for cancer susceptibility

R. Croyle, B. Reeve, C. Klabunde, 2003, American journal of medical genetics. Part A.

In Search of the Perfect Comorbidity Measure for Use With Administrative Claims Data: Does It Exist?

W. Barlow, C. Klabunde, L. Baldwin, 2006, Medical care.

The Role of Primary Care Physicians in Cancer Care

K. Kahn, N. Keating, C. Klabunde, 2009, Journal of General Internal Medicine.

Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer.

K. Kahn, N. Keating, R. Fletcher, 2014, Journal of the National Cancer Institute.

Primary Care Provider Attitudes are Associated With Smoking Cessation Counseling and Referral

Nancy Breen, Sally W. Vernon, L. Seeff, 2005, Medical care.

Increasing Colorectal Cancer Testing: Translating Physician Interventions Into Population-Based Practice

C. Klabunde, M. Pignone, A. Schenck, 2006, Health care financing review.

Measuring Multimorbidity

B. Ward, J. Silber, J. Suls, 2021, Medical care.

Differences Between Primary Care Physicians’ and Oncologists’ Knowledge, Attitudes and Practices Regarding the Care of Cancer Survivors

C. Earle, P. Ganz, C. Klabunde, 2011, Journal of General Internal Medicine.

Utility of the SEER-Medicare Data to Identify Chemotherapy Use

Beth A Virnig, Jean L Freeman, G. Cooper, 2002, Medical care.

U.S. primary care physicians' diet-, physical activity-, and weight-related care of adult patients.

D. Galuska, C. Klabunde, R. Ballard-Barbash, 2011, American journal of preventive medicine.

Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems

E. Halm, Chyke A Doubeni, C. Rutter, 2016, Cancer Epidemiology, Biomarkers & Prevention.

Fecal Occult Blood Testing Beliefs and Practices of U.S. Primary Care Physicians: Serious Deviations from Evidence-Based Recommendations

S. Coughlin, C. Klabunde, Robert A. Smith, 2010, Journal of General Internal Medicine.

Community Clinical Oncology Program participation in the Breast Cancer Prevention Trial: factors affecting accrual.

A. Kaluzny, C. Klabunde, L. Ford, 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

International Cancer Screening Network 2015

K. Kerlikowske, S. Taplin, C. Vidal, 2012 .

Are There Gender Differences in Colorectal Cancer Test Use Prevalence and Correlates?

W. Rakowski, C. Klabunde, S. Vernon, 2006, Cancer Epidemiology Biomarkers & Prevention.

Systems Strategies to Support Cancer Screening in U.S. Primary Care Practice

D. Haggstrom, D. Buckman, S. Taplin, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Cancer screening practices from National Health Interview Surveys: past, present, and future.

R. Hiatt, C. Klabunde, N. Breen, 2002, Journal of the National Cancer Institute.

The appropriateness of more intensive colonoscopy screening than recommended in Medicare beneficiaries: a modeling study.

A. Zauber, M. van Ballegooijen, I. Lansdorp-Vogelaar, 2014, JAMA internal medicine.

The Appropriateness ofMore Intensive Colonoscopy Screening Than Recommended inMedicare Beneficiaries AModeling Study

A. Zauber, I. Lansdorp-Vogelaar, S. L. Goede, 2014 .

Are Physicians Doing Too Much Colonoscopy? A National Survey of Colorectal Surveillance after Polypectomy

David F Ransohoff, D. Ransohoff, C. Klabunde, 2004, Annals of Internal Medicine.

Current capacity for endoscopic colorectal cancer screening in the United States: data from the National Cancer Institute Survey of Colorectal Cancer Screening Practices.

C. Klabunde, Martin L. Brown, P. Mysliwiec, 2003, The American journal of medicine.

Data systems to evaluate colorectal cancer screening practices and outcomes at the population level.

A. Dietrich, D. Lieberman, P. Carney, 2008, Medical care.

Improving Colorectal Cancer Screening in Primary Care Practice: Innovative Strategies and Future Directions

Robert H. Fletcher, David F. Ransohoff, David Lanier, 2007, Journal of General Internal Medicine.

Physicians' use of nonphysician healthcare providers for colorectal cancer screening.

C. Klabunde, Martin L. Brown, L. Sansbury, 2003, American journal of preventive medicine.

Colorectal cancer screening with double-contrast barium enema: a national survey of diagnostic radiologists.

Elizabeth G. Jones, C. Klabunde, Martin L. Brown, 2002, AJR. American journal of roentgenology.

Lung Cancer Screening Inconsistent With U.S. Preventive Services Task Force Recommendations.

C. Klabunde, T. Richards, M. White, 2019, American journal of preventive medicine.

Improving the Quality of Surveys of Physicians and Medical Groups

Sarah M. Greene, D. Dillman, G. Willis, 2012, Evaluation & the health professions.

Health Care Provider Surveys in the United States, 2000–2010

G. Willis, C. Klabunde, C. Mcleod, 2013, Evaluation & the health professions.

A population‐based study of colorectal cancer test use

C. Ko, C. Klabunde, N. Ponce, 2004, Cancer.

Evaluation of Claims, Medical Records, and Self-report for Measuring Fecal Occult Blood Testing among Medicare Enrollees in Fee for Service

D. Ransohoff, C. Klabunde, J. Warren, 2008, Cancer Epidemiology Biomarkers & Prevention.

Data Sources for Measuring Colorectal Endoscopy Use Among Medicare Enrollees

D. Ransohoff, C. Klabunde, J. Warren, 2007, Cancer Epidemiology Biomarkers & Prevention.

Use of Colonoscopy for Colorectal Cancer Screening

C. Klabunde, N. Breen, H. Meissner, 2005, Cancer Epidemiology Biomarkers & Prevention.

Comparing Interval Breast Cancer Rates in Norway and North Carolina: Results and Challenges

Solveig Hofvind, Jean-Luc Bulliard, B. Yankaskas, 2009, Journal of medical screening.

Technical quality control practices in mammography screening programs in 22 countries.

R. Hendrick, C. Klabunde, A. Grivegnée, 2002, International journal for quality in health care : journal of the International Society for Quality in Health Care.

Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines

A. Tosteson, T. Onega, J. Haas, 2015, Journal of General Internal Medicine.

Linking Physician Characteristics and Medicare Claims Data: Issues in Data Availability, Quality, and Measurement

C. Klabunde, Walter Adamache, L. Baldwin, 2002, Medical care.

Measuring Complications of Cancer Treatment Using the SEER-Medicare Data

Colin B Begg, Craig C Earle, C. Earle, 2002, Medical care.

Inadequate Systems to Support Breast and Cervical Cancer Screening in Primary Care Practice

Jennifer S. Haas, Marilyn M. Schapira, Brian L. Sprague, 2016, Journal of General Internal Medicine.

Primary Care Providers’ Beliefs and Recommendations and Use of Screening Mammography by their Patients

A. Tosteson, W. Barlow, T. Onega, 2017, Journal of General Internal Medicine.

Patterns of Colorectal Cancer Test Use, Including CT Colonography, in the 2010 National Health Interview Survey

L. Seeff, C. Klabunde, T. Thompson, 2012, Cancer Epidemiology, Biomarkers & Prevention.

The Contribution of Longitudinal Comorbidity Measurements to Survival Analysis

Laura-Mae Baldwin, C Y Wang, C. Y. Wang, 2009, Medical care.

Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity.

E. Conant, Chyke A Doubeni, M. Schnall, 2016, American journal of preventive medicine.

Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly.

E. Halm, Chyke A Doubeni, C. Rutter, 2016, American journal of preventive medicine.

Facilitators and Barriers to Survey Participation by Physicians

L. Casalino, G. Willis, C. Klabunde, 2013, Evaluation & the health professions.

Lung Cancer Screening Practices of Primary Care Physicians: Results From a National Survey

P. Marcus, G. Silvestri, C. Klabunde, 2012, The Annals of Family Medicine.

Sorting out measures and definitions of screening participation to improve comparability: the example of colorectal cancer.

J. Bulliard, Montse García, C. Klabunde, 2014, European journal of cancer.

Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening

Christopher D. Jensen, A. Zauber, Chyke A Doubeni, 2016, Annals of Internal Medicine.

Measures for ascertaining use of colorectal cancer screening in behavioral, health services, and epidemiologic research.

B. Rimer, D. Ahnen, C. Klabunde, 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Screening Colonoscopy in the US: Attitudes and Practices of Primary Care Physicians

Stephen Taplin, Sarah Kobrin, D. Ransohoff, 2012, Journal of General Internal Medicine.

Barriers to breast and colorectal cancer survivorship care: perceptions of primary care physicians and medical oncologists in the United States.

C. Earle, P. Ganz, C. Klabunde, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Physician roles in the cancer-related follow-up care of cancer survivors.

C. Earle, C. Klabunde, J. Rowland, 2013, Family medicine.

Reply to U. Tirelli et al.

C. Earle, P. Ganz, C. Klabunde, 2014, Journal of Clinical Oncology.

Factors influencing enrollment in clinical trials for cancer treatment.

C. Klabunde, J. Atkins, B. Springer, 1999, Southern medical journal.

Quality assurance for screening mammography: an international comparison

S. Taplin, C. Klabunde, A. Scharpantgen, 2001, Journal of epidemiology and community health.

Health plan policies and programs for colorectal cancer screening: a national profile.

C. Klabunde, M. Mandelson, P. Frame, 2004, The American journal of managed care.

A population-based assessment of specialty physician involvement in cancer clinical trials.

N. Keating, P. Ganz, C. Klabunde, 2011, Journal of the National Cancer Institute.

Are Physicians’ Recommendations For Colorectal Cancer Screening Guideline-Consistent?

D. Buckman, S. Taplin, C. Klabunde, 2011, Journal of General Internal Medicine.

Accrual to the Breast Cancer Prevention Trial by participating Community Clinical Oncology Programs: A panel data analysis

A. Kaluzny, C. Klabunde, 1995, Breast Cancer Research and Treatment.

Barriers to colorectal cancer screening among Medicare consumers.

C. Klabunde, W. Davis, Carrie N Klabunde, 2006, American journal of preventive medicine.

Adjuvant Chemotherapy for Stage III Colon Cancer

K. Kahn, N. Keating, R. Fletcher, 2008 .

Physicians’ Beliefs About Breast Cancer Surveillance Testing are Consistent With Test Overuse

Paul K J Han, Anne-Michelle Noone, Craig C Earle, 2013, Medical care.

Comparison of Cancer Diagnosis and Treatment in Medicare Fee-for-Service and Managed Care Plans

C. Klabunde, J. Warren, A. Potosky, 2008, Medical care.

Measuring Breast, Colorectal, and Prostate Cancer Screening With Medicare Claims Data

Beth A Virnig, Jean L Freeman, G. Cooper, 2002, Medical care.

Influence of provider discussion and specific recommendation on colorectal cancer screening uptake among U.S. adults.

Chyke A Doubeni, C. Klabunde, B. Cash, 2014, Preventive medicine.

Physician Visits and Colorectal Cancer Testing Among Medicare Enrollees in North Carolina and South Carolina, 2005

C. Klabunde, J. Warren, P. Lapin, 2011, Preventing chronic disease.

Improving colorectal cancer screening through research in primary care settings.

C. Klabunde, Martin L. Brown, H. Meissner, 2008, Medical care.

Comorbidities, therapy, and newly diagnosed conditions for women with early stage breast cancer

A. McTiernan, L. Bernstein, C. Klabunde, 2009, Journal of cancer survivorship : research and practice.

Physicians' reactions to change in recommendations for mammography screening.

A. Kaluzny, C. Klabunde, M. O’Malley, 1997, American journal of preventive medicine.

Methodological issues in international comparison of interval breast cancers

B. Yankaskas, J. Bulliard, C. Klabunde, 2006, International journal of cancer.

Breast cancer screening in 21 countries: delivery of services, notification of results and outcomes ascertainment.

S. Shapiro, G. Rennert, E. Paci, 1999, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

The Colorectal Cancer Screening Process in Community Settings: A Conceptual Model for the Population-Based Research Optimizing Screening through Personalized Regimens Consortium

Yingye Zheng, Karen J Wernli, Jasmin A Tiro, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Population-based survivorship research using cancer registries: a study of non-Hodgkin’s Lymphoma survivors

C. Klabunde, J. Rowland, A. Potosky, 2007, Journal of cancer survivorship : research and practice.

Variations in Surgeon Treatment Recommendations for Lobectomy in Early-Stage Non-Small-Cell Lung Cancer by Patient Age and Comorbidity

K. Kahn, N. Keating, R. Fletcher, 2010, Annals of Surgical Oncology.

Characteristics of Scientific Evidence Informing Changed U.S. Preventive Services Task Force Insufficient Evidence Statements.

C. Klabunde, Q. Ngo-Metzger, Erin M. Ellis, 2021, American journal of preventive medicine.

U.S. primary care physicians' lung cancer screening beliefs and recommendations.

P. Marcus, G. Silvestri, C. Klabunde, 2010, American journal of preventive medicine.

Racial differences in colorectal cancer test use by Medicare consumers.

C. Klabunde, W. Davis, A. Schenck, 2006, American journal of preventive medicine.

Colorectal cancer screening perceptions and practices: Results from a national survey of gastroenterology, surgery and radiology trainees

R. Vierkant, D. Hough, T. Hartman, 2009, Journal of Cancer Education.

Do Patients Consistently Report Comorbid Conditions Over Time?: Results From the Prostate Cancer Outcomes Study

B. Reeve, C. Klabunde, A. Potosky, 2005, Medical care.

Opioids and Chronic Pain: Impact of the NIH Pathways to Prevention Evidence-Based Workshop Program

C. Klabunde, Luis F. Ganoza, David A. Thomas, 2023, Prevention Science.

Physician over‐recommendation of mammography for terminally ill women

C. Klabunde, J. Rowland, C. Alfano, 2012, Cancer.

Adoption of CT colonography by US hospitals.

C. Klabunde, Barbara A Galen, M. McHugh, 2011, Journal of the American College of Radiology : JACR.

Opportunities and Challenges for the Use of Large-Scale Surveys in Public Health Research: A Comparison of the Assessment of Cancer Screening Behaviors

R. Moser, C. Klabunde, N. Breen, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Physician Recommendations for Follow-Up of Positive Fecal Occult Blood Tests

C. Klabunde, Martin L. Brown, K. Yabroff, 2005, Medical care research and review : MCRR.

Life tables adjusted for comorbidity more accurately estimate noncancer survival for recently diagnosed cancer patients.

E. Feuer, A. Mariotto, Hyunsoon Cho, 2013, Journal of clinical epidemiology.

Colorectal Cancer Test Use from the 2005 National Health Interview Survey

L. Seeff, C. Klabunde, S. Vernon, 2008, Cancer Epidemiology Biomarkers & Prevention.

Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems

E. Halm, Chyke A Doubeni, C. Rutter, 2016, Cancer Epidemiology, Biomarkers & Prevention.

Colorectal Cancer Screening in US Seniors Ages 76–84 Years

C. Klabunde, J. Shapiro, M. Nadel, 2015, Journal of Community Health.

Physician roles in the cancer-related follow-up care of cancer survivors.

C. Earle, C. Klabunde, J. Rowland, 2013, Family medicine.

Proceedings from the 9th annual conference on the science of dissemination and implementation

Caitlin N. Dorsey, Robert D. Lieberthal, Julie E. Reed, 2017, Implementation Science.